From Insight to Impact: Strategic Growth Mapping in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth Performance Trended Historically, And What Lies Ahead?
In recent times, the market size of minimally invasive glaucoma surgery (MIGS) devices has seen a significant expansion. The market, valued at $0.7 billion in 2024, is predicted to hit $0.89 billion in 2025, rising at a compound annual growth rate (CAGR) of 27.6%. Factors that have contributed to this growth in the past include amplified awareness about preventing blindness, augmentation in healthcare infrastructure investments, improved patient knowledge concerning cutting-edge corrective vision treatments, increased awareness about these treatments, and enhanced government initiatives.
The market for minimally invasive glaucoma surgery (migs) devices is projected to witness robust growth in the upcoming years, escalating to $2.29 billion in 2029 with a compound annual growth rate (CAGR) of 26.5%. The anticipated rise during the forecast period can be associated with the surging prevalence of eye conditions such as glaucoma, an increase in the elderly population, a burgeoning healthcare infrastructure, and a growing demand for safer and more effective treatments. Significant trends expected during this forecast period encompass the incorporation of MIGS devices, technological advancements, the creation of innovative minimally invasive glaucoma surgery devices, the introduction of sophisticated implantable devices, and progress in ophthalmic technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
What are the Fundamental Drivers and Innovations Shaping the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The escalating cases of vision-related conditions are anticipated to fuel the expansion of the minimally invasive glaucoma surgery (MIGS) devices market. These conditions vary, impacting the eyes and vision. Their growing incidence is tied to lifestyle transformations, ecological factors, and aging demographics. MIGS devices are pioneering instruments used to manage an array of eye ailments, with a key thrust on lowering intraocular pressure (IOP) to impede or regulate glaucoma progression. For example, as per the US’s National Eye Institute data, approximately 2.2 million Americans are expected to lose some or all vision by 2030. Consequently, the surging cases of eye disorders are driving the growth of the MIGS devices market.
How Is the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmented?
The minimally invasive glaucoma surgery (migs) devicesmarket covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp
Which Regions Are Driving the Next Phase of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading businesses in the minimally invasive glaucoma surgery (MIGS) devices sector are concentrating their efforts on creating novel product offerings such as stent injectable systems. These innovations are specifically designed to address the unrecognized gaps in glaucoma treatment and consequently better patient results. A stent injectable system is an example of a MIGS device which is used to implant a small stent, using a procedure similar to injection, typically with a specialized delivery method used in minimally invasive surgeries like addressing issues of blocked or narrowed blood vessels. For example, Glaukos Corporation, a US-based ophthalmic medical technology company, gained clearance from the U.S. Food and Drug Administration (FDA) in August 2022 for its iStent Infinite Trabecular Micro-Bypass System. This innovative three-stent injectable system (iStent Infinite) has been developed to consistently control intraocular pressure (IOP) 24/7 for patients with primary open-angle glaucoma (POAG) who cannot manage their IOP with earlier medication and surgical treatment.
View the full report here:
How Is the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Defined and What Are Its Core Parameters?
Minimally invasive glaucoma surgery (MIGS) devices are medical instruments designed to lower intraocular pressure (IOP) in patients with glaucoma through less invasive surgical techniques compared to traditional glaucoma surgeries. These devices aim to reduce the risk of complications, shorten recovery time, and improve patient outcomes by offering a safer and less invasive option for patients needing surgical intervention to manage their condition.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
